0001062993-20-004584.txt : 20200921 0001062993-20-004584.hdr.sgml : 20200921 20200921161928 ACCESSION NUMBER: 0001062993-20-004584 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200918 FILED AS OF DATE: 20200921 DATE AS OF CHANGE: 20200921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McAvoy David R. CENTRAL INDEX KEY: 0001758842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 201186498 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC., 3000 KENT AVENUE STREET 2: SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brickell Biotech, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-09-18 0000819050 Brickell Biotech, Inc. BBI 0001758842 McAvoy David R. C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301 0 1 0 0 General Counsel and CCO Common Stock 2020-09-18 4 P 0 16526 .8298 A 75883 D Common Stock 2020-09-18 4 P 0 6000 0.8398 A 6000 I By spouse Represents the purchase of 16,526 shares in multiple transactions, ranging in price from $0.8224 to $0.8429 per share, resulting in a weighted average purchase price of $0.8298. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range. /s/ Christine G. Long, Attorney-in-Fact for David R. McAvoy (power of attorney previously filed) 2020-09-21